As of Aug 28
| +0.03 / +0.03%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 120.00, with a high estimate of 130.00 and a low estimate of 80.00. The median estimate represents a +22.16% increase from the last price of 98.23.
The current consensus among 11 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.